| Particulars |
|
|
|
| Company Name
| Aurobindo Pharma Ltd
| Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
58.08 |
B.V. (₹) |
391.10 |
| Sales(₹ Cr.) |
11,055.39 |
NP (₹ Cr.) |
2,428.07 |
| NP Var% |
39.00 |
Div% |
400.00 |
| CPS(₹) |
46.70 |
EPS (₹) |
41.80 |
| Traded Value(₹ Lakhs) |
594.89 |
52 Week High |
1,565.00 |
| 52 Week Low |
1,017.00 |
Price BSE |
1,555.00 |
| Price NSE |
1,555.00 |
Market Capital (₹ Cr.) |
90,311.75 |
| P/C Ratio |
33.30 |
P/E Ratio |
37.20 |
| Price Vs.BV |
3.98 |
|
| Latest Quarter |
| Year End |
202603 |
Sales (₹ Cr.) |
2,746.98 |
| NP(₹ Cr.) |
692.23 |
NP Var % |
70.00 |
| Trailing Twelve Months |
| Year End |
202603 |
Sales |
10,713.37 |
| OPM |
23.28 |
NP |
2,069.02 |
| NP Var% |
39.44 |
EPS |
41.81 |
| PE |
37.19 |
|
|